Smoking is one of the major lifestyle factors influencing the health of human beings. Life-
long cigarette smokers have a higher prevalence of common diseases such as …

Background Smoking is a well-established risk factor for atherosclerotic disease, but its role
as an independent risk factor for venous thromboembolism (VTE) remains controversial. We …

Aims To examine the associations between cigarette smoking, pipe/cigar smoking, and
years since quitting smoking, and inflammatory and haemostatic markers. Methods and …

Objective. There is still debate whether type II endoleaks represent a risk for the patient after
EVAR. Treatment policies vary from fairly conservative to active intervention. In this analysis …

Background—Few studies have examined whether hemostatic markers contribute to risk of
coronary disease and ischemic stroke independently of conventional risk factors. This study …

Background Multiple pleiotropic effects of statins include antithrombotic properties with
formation of looser fibrin networks more susceptible to lysis. Recently, rosuvastatin 20 mg/d …

Background. Elevated plasma levels of interleukin (IL)-6, C-reactive protein (CRP), and D-
dimer belong to the biological alterations of the “frailty syndrome,” defining increased …

Background: Previous studies have shown that idiopathic pulmonary embolism is positively
associated with other cardiovascular events, such as myocardial infarction and stroke …

To explore the molecular basis of von Willebrand factor (VWF) clearance, an experimental
model employing VWF-deficient mice was developed. Biodistribution was examined by the …

OBJECTIVE To assess whether stopping smoking can improve erectile dysfunction (ED) in
smokers, as cigarette smoking is a known risk factor for ED. PATIENTS AND METHODS …